BMO Capital Markets Begins Coverage on Novo Nordisk A/S (NYSE:NVO)

BMO Capital Markets assumed coverage on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a report published on Friday morning, MarketBeat reports. The brokerage issued an outperform rating and a $163.00 target price on the stock. Several other research analysts also recently commented on NVO. UBS Group started coverage on Novo Nordisk A/S […]

Leave a Reply

Your email address will not be published.

Previous post Stephens Begins Coverage on Portillo’s (NASDAQ:PTLO)
Next post Domino’s Pizza (NYSE:DPZ) Earns “Equal Weight” Rating from Stephens